6 November 2025

PBS Pharmaceuticals

New PBS listing for front-line lymphoma therapy

6 November 2025

Cancer Clinical research Pharmaceuticals

More DOACs is not always better for minimising VTE risk

6 November 2025

Menopause Pharmaceuticals Women

The Menopause Society conference wrap up

9 October 2025

Pharmaceuticals Public Health TGA

TGA flags unsafe melatonin imports after lab test failures

28 August 2025

Obesity Pharmaceuticals

GLP-1 drugs linked to lower cancer risk

17 July 2025

FDA Haematology Pharmaceuticals

Myeloma drug scores FDA approval

17 July 2025

Pain Pharmaceuticals Research

First human evidence for resiniferatoxin in cancer pain

3 July 2025

PBAC Pharmaceuticals

Liver, endometrial and lung cancer drugs discussed at PBAC

3 July 2025

Research Sarcoma

Soft tissue sarcoma drug passes phase 2a trial

19 June 2025

Breast cancer Genetics Pharmaceuticals

Potential classification, treatment changes in HER2 breast cancer

5 June 2025

Lung cancer PBS Pharmaceuticals

Targeted lung cancer therapy added to PBS

22 May 2025

Cancer Pharmaceuticals TGA

‘Important step forward’ in endometrial cancer treatment

22 May 2025

Immune Checkpoint Inhibitors Rheumatology

The great checkpoint inhibitor balancing act

22 May 2025

Leukaemia Pharmaceuticals

Statins linked to improved survival in leukaemia

22 May 2025

Cancer Immune Checkpoint Inhibitors

ICI use predicted to increase despite adverse events: study

8 May 2025

Pharmaceuticals Prostate cancer

Combination therapy shows promise for prostate cancer

24 April 2025

Cancer PBS

Aussie myelofibrosis drug added to PBS

10 April 2025

Leukaemia Pharmaceuticals

Real-world data backs AML treatment

10 April 2025

Hepatocellular carcinoma Research

Three treatments are better than one for liver cancer

10 April 2025

Breast cancer TGA

Ribociclib welcomed in by TGA